Is Your Company 'Corpomorphic'?

By Fintan Walton

PharmaDeals Review: Vol 2006 Issue 67 (Table of Contents)

Published: 1 Jan-2006

DOI: 10.3833/pdr.v2006i67.579     ISSN: 1756-7874

Section: Business Commentaries

Fulltext:

Abstract

Which business model should a biotech company adopt? Changing attitudes and fluctuating financial markets make it very difficult for companies to set a long-term vision to a particular business model. However, the ability to morph from one business model to another is characteristic of many companies.

Copyright: PharmaVentures Ltd

Bookmarks

Bookmark PharmaDeals through one of these social networks.